Similar Articles
271 Identification of immune cell-related prognostic genes characterized by a distinct microenvironment in hepatocellular carcinoma
272 From prediction to prevention: Machine learning revolutionizes hepatocellular carcinoma recurrence monitoring
273 Progress in the treatment of advanced hepatocellular carcinoma with immune combination therapy
274 Prognostic value of circulating tumor cells combined with neutrophil-lymphocyte ratio in patients with hepatocellular carcinoma
275 Comprehensive analysis of the protein phosphatase 2A regulatory subunit B56ε in pan-cancer and its role and mechanism in hepatocellular carcinoma
276 Leveraging machine learning for early recurrence prediction in hepatocellular carcinoma: A step towards precision medicine
277 Current status of magnetic resonance imaging radiomics in hepatocellular carcinoma: A quantitative review with Radiomics Quality Score
278 Direct-acting antivirals failed to reduce the incidence of hepatocellular carcinoma occurrence in hepatitis C virus associated cirrhosis: A real-world study
279 Rifaximin on epigenetics and autophagy in animal model of hepatocellular carcinoma secondary to metabolic-dysfunction associated steatotic liver disease
280 Sorafenib plus transarterial chemoembolization vs sorafenib alone for patients with advanced hepatocellular carcinoma: A systematic review and meta-analysis
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA